🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Could agree more ! Nathan A. Pennell MD, PhD, FASCO Hope Rugo

Beyond delighted to see super ⭐️ and a truly genuine human being Amin Nassar, MD get his ASCO Conquer Cancer, the ASCO Foundation YIA 🎊 . I would joke with him that if someone like him doesn’t get it, I would begin to Q a lot of things 😅 But faith restored !!😁

Join us at #ASCO2025 on June 1 at 12 p.m. CDT in Arie Crown Theater, where Dr. Melissa Johnson will join fellow experts to break down real-world use of amivantamab & tarlatamab for #lungcancer, covering efficacy, toxicities & patient experience. dailynews.ascopubs.org/do/do-recent-a…

Come by poster 301 Conquer Cancer, the ASCO Foundation merit 🥇Sagal Pannu OU Health Stephenson Cancer Center presenting on pantumor potential liquid biopsy implications for subsequent germline testing for DDR alterations! ASCO

Watch out for these OU superstar medical students who presented their work at #ASCO25 & ASCO TECAG Med Student Abstract Forum today!!

Congratulations to the team!! with stellar mentor Biagio Ricciuti, MD PhD !

Congratulations Eric K. Singhi, MD !!

At #ASCO25, Dr. Naqash explores the promise & challenges of bispecific T-cell engagers (BiTEs) in lung cancer & beyond: ✅ Tarlatamab earns FDA nod for SCLC ⚠️ CRS & ICANS toxicity management is key 🎯 DLL3 & other targets may expand BiTE reach #Immunotherapy #LungCancer

Dr. Rafeh Naqash, MD walks us through DeLLphi-301 and ongoing BiTEs targeting #DLL3 . 🧠With tarlatamab, we cannot forget that ICANS can occur much later than what we see in heme malignancies 🧠ASCO #ASCO25 #lcsm #lcam #SCLC

Congratulations to Erika Hamilton, MD DrZon Eric J. Small, MD, FASCO Cardinale B. Smith on a fantastic ASCO #ASCO25 and a fantastic start to the plenary session !! Sarah Cannon Docs Skip Burris, MD Vivek Subbiah, MD

There are some of the real ⭐️ behind the scenes who make ASCO a success every year every time! #ASCO2025 #ASCOStaff! Amanda Narod Erika Hamilton, MD Eric J. Small, MD, FASCO . Impossible to do what needs to be done without them 👍👏

Such elegant work by Dr. Elias Bou Farhat (conquer cancer recipient)! Excited to see this effort come to light. If you’re interested in cancer genomics, keep an eye on this guy and give him a follow Rafeh Naqash, MD ASCO

Expert discussant #RadOnc Professor Shankar Siva Shankar Siva Peter Mac Cancer Centre bringing Professor #Sparkles to dissect lung orals for ACHILES atezo post CCRT, SWOG Cancer Research Network SBRT+atezo, & R-ALPS at #ASCO25.

A great session with practice changing results. Kudos to chairs, speakers, and discussants. One of the best sessions during #ASCO25. Rafeh Naqash, MD Pramesh CS

Stellar trainee Ayesha Aijaz OU Health Stephenson Cancer Center presented today ASCO #ASCO25 on ICI induced non inflammatory sarcoid like reaction. Now a global cohort from more than 20 centers > 140 pts!! OU DOM Resident Research IMG Oncologists

Was an honor chairing 🫁 orals with Pramesh CS #ASCO25 were in 30 min we saw more progress than we have seen in over 30 years for #SCLC #IMforte #DeLLphi-304 and #ZG006 TriTE!! Congratulations to all the presenters. This session had two NEJM one The Lancet and one Journal of Clinical Oncology !

Last day of #ASCO25!! If you’re still in Chicago this morning, please join us for the highlights of the day session!! 📍Hall D1 ASCO MD Anderson Cancer Center

🚨 Don’t miss our educational session today! 📍 E450A, 8 AM CT 🎤 Kaushal Parikh Biagio Ricciuti, MD, PhD ASCO #ASCO25 OncoAlert #LCSM

Congratulations Tian Zhang, MD, MHS Ryan Nipp, MD, MPH, MBA, FASCO Charles Jiang MD, MPH on this state of the art review on clinical trial access in NatureRevClinOncol!

Immune Checkpoint Inhibitors for Patients With Autoimmune Neurologic Disorders. Fantastic realworld collaboration on a clinically relevant Q, JAMA Network Open jamanetwork.com/journals/jaman…